Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Traynor

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide g3139, in combination with carboplatin and paclitaxel, in patients with advanced solid tumorsGlenn Liu, Jill Kolesar, Douglas G McNeel, et al.
Frontiers in Veterinary Science|November 24, 2018
Reliability and Validity Assessment of the Observation of Human-Animal Interaction for Research (OHAIRE) Behavior Coding ToolNoémie A Guérin, Robin L Gabriels, Monique M Germone, et al.
Clinical Breast Cancer|May 3, 2016
Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network StudyKari B Wisinski, Wei Xu, Amye J Tevaarwerk, et al.
Frontiers in Rehabilitation Sciences|October 3, 2022
Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and UltrasoundJevin Lortie, Benjamin Rush, Katie Osterbauer, et al.
Frontiers in Rehabilitation Sciences|October 3, 2022
Corrigendum: Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and UltrasoundJevin Lortie, Benjamin Rush, Katie Osterbauer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2018
Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLCJessica J Lin, Viola W Zhu, Adam J Schoenfeld, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2023
MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or ChemotherapyKai He, David Berz, Shirish M Gadgeel, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide g3139, in combination with carboplatin and paclitaxel, in patients with advanced solid tumorsGlenn Liu, Jill Kolesar, Douglas G McNeel, et al.
Frontiers in Veterinary Science|November 24, 2018
Reliability and Validity Assessment of the Observation of Human-Animal Interaction for Research (OHAIRE) Behavior Coding ToolNoémie A Guérin, Robin L Gabriels, Monique M Germone, et al.
Clinical Breast Cancer|May 3, 2016
Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network StudyKari B Wisinski, Wei Xu, Amye J Tevaarwerk, et al.
Frontiers in Rehabilitation Sciences|October 3, 2022
Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and UltrasoundJevin Lortie, Benjamin Rush, Katie Osterbauer, et al.
Frontiers in Rehabilitation Sciences|October 3, 2022
Corrigendum: Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and UltrasoundJevin Lortie, Benjamin Rush, Katie Osterbauer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2018
Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLCJessica J Lin, Viola W Zhu, Adam J Schoenfeld, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2023
MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or ChemotherapyKai He, David Berz, Shirish M Gadgeel, et al.
Pageof 2